• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤分布影响多发性上尿路尿路上皮癌行根治性肾输尿管切除术患者的膀胱复发率,但不影响其生存结局。

Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.

机构信息

School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Department of Urology, China Medical University and Hospital, Taichung, Taiwan.

出版信息

Sci Rep. 2021 Sep 24;11(1):19059. doi: 10.1038/s41598-021-98696-0.

DOI:10.1038/s41598-021-98696-0
PMID:34561545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8463529/
Abstract

Tumor multifocality and location are prognostic factors for upper tract urothelial carcinoma (UTUC). However, confounding effects can appear when these two factors are analyzed together. Therefore, we aimed to investigate the impact of tumor distribution on the outcomes of multifocal UTUC after radical nephroureterectomy. From the 2780 UTUC patients in the Taiwan UTUC Collaboration Group, 685 UTUC cases with multifocal tumors (defined as more than one tumor lesion in unilateral upper urinary tract) were retrospectively included and divided into three groups: multiple renal pelvic tumors, multiple ureteral tumors, and synchronous renal pelvic and ureteral tumors included 164, 152, and 369 patients, respectively. We found the prevalence of carcinoma in situ was the highest in the synchronous group. In multivariate survival analyses, tumor distribution showed no difference in cancer-specific and disease-free survival, but there was a significant difference in bladder recurrence-free survival. The synchronous group had the highest bladder recurrence rate. In summary, tumor distribution did not influence the cancer-specific outcomes of multifocal UTUC, but synchronous lesions led to a higher rate of bladder recurrence than multiple renal pelvic tumors. We believe that the distribution of tumors reflects the degree of malignant involvement within the urinary tract, but has little significance for survival or disease progression.

摘要

肿瘤多灶性和位置是上尿路上皮癌(UTUC)的预后因素。然而,当这两个因素一起分析时,可能会出现混杂效应。因此,我们旨在研究根治性肾输尿管切除术治疗多灶性 UTUC 后肿瘤分布对其结果的影响。从台湾 UTUC 协作组的 2780 例 UTUC 患者中,回顾性纳入 685 例多灶性 UTUC 患者(定义为单侧上尿路有多个肿瘤病变),并将其分为三组:多发肾盂肿瘤、多发输尿管肿瘤和同时性肾盂和输尿管肿瘤,分别包括 164、152 和 369 例患者。我们发现同时性组原位癌的患病率最高。多变量生存分析显示,肿瘤分布在癌症特异性和无病生存率方面无差异,但在膀胱无复发生存率方面有显著差异。同时性组的膀胱复发率最高。总之,肿瘤分布并不影响多灶性 UTUC 的癌症特异性结局,但同步病变导致膀胱复发的几率高于多发肾盂肿瘤。我们认为肿瘤的分布反映了尿路内恶性浸润的程度,但对生存或疾病进展意义不大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/7a2cb94fe86a/41598_2021_98696_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/346242f94f3e/41598_2021_98696_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/68ae12f47190/41598_2021_98696_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/7a2cb94fe86a/41598_2021_98696_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/346242f94f3e/41598_2021_98696_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/68ae12f47190/41598_2021_98696_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7480/8463529/7a2cb94fe86a/41598_2021_98696_Fig3_HTML.jpg

相似文献

1
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy.肿瘤分布影响多发性上尿路尿路上皮癌行根治性肾输尿管切除术患者的膀胱复发率,但不影响其生存结局。
Sci Rep. 2021 Sep 24;11(1):19059. doi: 10.1038/s41598-021-98696-0.
2
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.非肌层浸润性膀胱肿瘤史对上尿路尿路上皮癌患者的预后意义。
Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.
3
Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.台湾上尿路尿路上皮癌的肿瘤学结局的性别效应。
Int Urol Nephrol. 2020 Jun;52(6):1043-1048. doi: 10.1007/s11255-020-02396-z. Epub 2020 Jan 29.
4
Comparison of intravesical chemotherapy regimens after radical nephroureterectomy for upper tract urothelial carcinoma and analysis of risk factors for postoperative recurrence.根治性肾输尿管切除术治疗上尿路上皮癌术后膀胱内化疗方案的比较及术后复发的危险因素分析。
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2387-2395. doi: 10.26355/eurrev_202403_35745.
5
Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.根治性肾输尿管切除术治疗上尿路上皮癌后膀胱内卡介苗治疗后续非肌层浸润性膀胱癌的结果。
BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.
6
Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.既往或同期非肌层浸润性膀胱癌对上尿路尿路上皮癌根治性肾输尿管切除术后临床结果的影响:一项多机构研究
Urol J. 2015 Sep 4;12(4):2233-9.
7
Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.基于肿瘤位置的上尿路尿路上皮癌分割对无尿路上皮复发生存的影响:一项多机构数据库研究
Curr Urol. 2020 Dec;14(4):183-190. doi: 10.1159/000499240. Epub 2020 Dec 18.
8
Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study.巴尔干地方性肾病和性别对根治性肾输尿管切除术治疗上尿路上皮癌结局的预后价值:一项队列研究。
Urol Oncol. 2021 Nov;39(11):786.e9-786.e16. doi: 10.1016/j.urolonc.2021.03.016. Epub 2021 May 15.
9
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中,肿瘤位置与多灶性的影响:无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.
10
Bladder recurrence of primary upper tract urinary carcinoma following nephroureterectomy, and risk of upper urinary tract recurrence after ureteral stent positioning in patients with primary bladder cancer.根治性肾输尿管切除术后原发性上尿路尿路上皮癌的膀胱复发,以及原发性膀胱癌患者输尿管支架置入术后上尿路复发的风险。
Minerva Urol Nefrol. 2019 Jun;71(3):191-200. doi: 10.23736/S0393-2249.19.03311-3. Epub 2019 Jan 17.

引用本文的文献

1
Is the presence of upper tract transitional cell carcinoma in a calyceal diverticulum a risk factor for early metastasis? A case report and review of the literature.肾盂憩室内上尿路移行细胞癌的存在是否为早期转移的危险因素?一例病例报告及文献综述。
SAGE Open Med Case Rep. 2024 Sep 30;12:2050313X241288341. doi: 10.1177/2050313X241288341. eCollection 2024.
2
Preoperative systemic inflammation response index enhances the prognostic value of tumor multifocalityin upper tract urothelial carcinoma.术前全身炎症反应指数增强了肿瘤多灶性在上尿路尿路上皮癌中的预后价值。
Oncol Lett. 2024 Jul 15;28(3):436. doi: 10.3892/ol.2024.14569. eCollection 2024 Sep.
3

本文引用的文献

1
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
2
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan.肾输尿管切除术治疗上尿路尿路上皮癌时原发肿瘤位置的预后意义:台湾一项回顾性多中心队列研究
J Clin Med. 2020 Nov 27;9(12):3866. doi: 10.3390/jcm9123866.
3
Cancer risk in Korean patients with gout.韩国痛风患者的癌症风险。
Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.
上尿路尿路上皮癌手术后复发性膀胱癌的临床特征及治疗现状
Diagnostics (Basel). 2023 Mar 6;13(5):1004. doi: 10.3390/diagnostics13051004.
4
Automated predictive analytics tool for rainfall forecasting.自动化预测分析工具,用于降雨预测。
Sci Rep. 2021 Sep 6;11(1):17704. doi: 10.1038/s41598-021-95735-8.
Korean J Intern Med. 2022 Mar;37(2):460-467. doi: 10.3904/kjim.2020.259. Epub 2021 Mar 23.
4
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.欧洲泌尿外科学会上尿路尿路上皮癌指南:2020 年更新版。
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
5
Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.台湾上尿路尿路上皮癌的肿瘤学结局的性别效应。
Int Urol Nephrol. 2020 Jun;52(6):1043-1048. doi: 10.1007/s11255-020-02396-z. Epub 2020 Jan 29.
6
Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?肾盂和输尿管尿路上皮癌:位置有影响吗?
Clin Genitourin Cancer. 2020 Feb;18(1):45-49.e1. doi: 10.1016/j.clgc.2019.10.023. Epub 2019 Nov 6.
7
Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China.中国中部地区上尿路尿路上皮癌患者的预后和风险因素以及膀胱癌术后复发。
BMC Urol. 2019 Apr 18;19(1):24. doi: 10.1186/s12894-019-0457-5.
8
Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy.肿瘤位置对上尿路尿路上皮癌肾输尿管切除术后局部复发的影响:对辅助放疗的启示
Clin Genitourin Cancer. 2017 Apr;15(2):e199-e204. doi: 10.1016/j.clgc.2016.07.010. Epub 2016 Jul 21.
9
Lower ureteral lesion is an independent predictor of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.输尿管下段病变是上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的独立预测因素。
Urol Oncol. 2016 Feb;34(2):59.e9-13. doi: 10.1016/j.urolonc.2015.08.015. Epub 2015 Sep 26.
10
The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis.肿瘤位置和多灶性对上尿路尿路上皮癌患者预后的影响:一项荟萃分析。
Sci Rep. 2014 Sep 15;4:6361. doi: 10.1038/srep06361.